Ex9536-4665
Research payments
$1,915,691
Through program year 2025, $1,915,691 in research payments was reported against Ex9536-4665, across 5,664 payments.
- Paid by (largest first)
- Novo Nordisk AS; Novo Nordisk Inc
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $750 | 1 |
| 2024 | Research | $31,400 | 6 |
| 2023 | Research | $413,561 | 146 |
| 2022 | Research | $948,893 | 1,994 |
| 2021 | Research | $483,524 | 3,505 |
| 2020 | Research | $37,563 | 12 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Mohammad Tahir Bridgeton, MO Named on 527 payments
- Ambarish Pandey Dallas, TX Named on 305 payments
- Kavita Sharma Baltimore, MD Named on 267 payments
- Gregory Egnaczyk Cincinnati, OH Named on 247 payments
- Steven Lupovitch Evanston, IL Named on 236 payments
- Stuart Prenner Philadelphia, PA Named on 222 payments
- Lokesh Chandra Burr Ridge, IL Named on 212 payments
- Chen Hoe Chow Topeka, KS Named on 187 payments
- Mikhail Kosiborod Kansas City, MO Named on 178 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.